EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic activity of mupirocin in combination with protocatechuic acid ethyl ester against mupirocin-resistant MRSA

Li Shen, Jinjin Yang, Zhixuan Chen, Jiana Fu, Huilin Zhao, Jianbo Lv, Yu Huang, Xinru Yuan, Haojin Gao, Fangyou Yu, Chunchan Lin, Jingyi Yu

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1722886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Li Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Mupirocin, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus, Hydroxybenzoates. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of mupirocin resistance in MRSA severely limits therapeutic options for skin and soft tissue infections. This study aimed to evaluate the potential synergistic activity between mupirocin and protocatechuic acid ethyl ester (EDHB) through in vitro and in vivo investigations. Clinical S. aureus isolates were characterized for antibiotic resistance profiles and molecular features via antimicrobial susceptibility testing, MLST, and spa typing. For MRSA isolates, checkerboard and time-kill assays were performed to assess in vitro synergy. The potential interference of EDHB with bacterial membrane integrity and efflux pumps was investigated using propidium iodide and ethidium bromide, respectively. The disk diffusion method was applied to test the retained antimicrobial activity of mupirocin and EDHB in ointment formulations. A murine dermal wound model was established to evaluate in vivo efficacy by topical application of mupirocin and EDHB, alone or in combination, on infected wounds. EDHB alone exhibited limited activity but synergistically reduced mupirocin MICs by 4-8-fold in most strains. Checkerboard analysis revealed synergistic or partial synergistic interactions against MRSA. Time-kill curves further indicated that combining these two drugs can effectively inhibit the planktonic S. aureus . EDHB rapidly disrupts cytoplasmic membrane integrity via concentration-dependent propidium iodide influx, independent of norA / mepA efflux pump modulation. The enhanced antibacterial activity of mupirocin and EDHB was sustained in ointment formulations, resulting in superior therapeutic outcomes with combination therapy compared to monotherapy. EDHB acts as a membrane-disrupting adjuvant that synergizes with mupirocin against MuR-MRSA, offering a promising strategy to combat recalcitrant S. aureus infections through localized combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MupirocinAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusHydroxybenzoatesStaphylococcal Skin InfectionsDrug SynergismDrug Therapy, CombinationMicrobial Sensitivity TestsFemaleAnimalsMiceMice, Inbred BALB C

Stichwörter der Autor:innen

Staphylococcus aureusantibiotic resistancemupirocinprotocatechuic acid ethyl estersynergistic activity

Substanzen

MupirocinAnti-Bacterial Agentsprotocatechuic acidHydroxybenzoates

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Zitieren

APA

Shen, L., Yang, J., Chen, Z., Fu, J., Zhao, H., Lv, J., Huang, Y., Yuan, X., Gao, H., Yu, F., Lin, C., & Yu, J. (2026). Synergistic activity of mupirocin in combination with protocatechuic acid ethyl ester against mupirocin-resistant MRSA. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1722886

Vancouver

Shen L, Yang J, Chen Z, Fu J, Zhao H, Lv J, et al. Synergistic activity of mupirocin in combination with protocatechuic acid ethyl ester against mupirocin-resistant MRSA. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1722886

BibTeX
@article{Shen2026,
  author = {Shen, Li and Yang, Jinjin and Chen, Zhixuan and Fu, Jiana and Zhao, Huilin and Lv, Jianbo and Huang, Yu and Yuan, Xinru and Gao, Haojin and Yu, Fangyou and Lin, Chunchan and Yu, Jingyi},
  title = {Synergistic activity of mupirocin in combination with protocatechuic acid ethyl ester against mupirocin-resistant MRSA},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1722886}
}
Kostenlos starten →